Mary Wilson
Well-known member
September 9, 2022
http://dx.doi.org/10.15585/mmwr.mm7136a1
Kathryn G. Curran, PhD[SUP]1[/SUP]; Kristen Eberly, MPH[SUP]1[/SUP]; Olivia O. Russell, MPH[SUP]2[/SUP]; Robert E. Snyder, PhD[SUP]3[/SUP]; Elisabeth K. Phillips, MPH[SUP]3[/SUP]; Eric C. Tang, MD[SUP]3[/SUP]; Philip J. Peters, MD[SUP]1[/SUP][SUP],3[/SUP]; Melissa A. Sanchez, PhD[SUP]4[/SUP]; Ling Hsu, MPH[SUP]4[/SUP]; Stephanie E. Cohen, MD[SUP]4[/SUP]; Ekow K. Sey, PhD[SUP]5[/SUP]; Sherry Yin, MPH[SUP]5[/SUP]; Chelsea Foo, MPH[SUP]5[/SUP]; William Still, MS[SUP]6[/SUP]; Anil Mangla, PhD[SUP]6[/SUP]; Brittani Saafir-Callaway, PhD[SUP]6[/SUP]; Lauren Barrineau-Vejjajiva, MPH[SUP]7[/SUP]; Cristina Meza, MPH[SUP]7[/SUP]; Elizabeth Burkhardt, MSPH[SUP]7[/SUP]; Marguerite E. Smith, MS, MPH[SUP]8[/SUP]; Patricia A. Murphy, MPH[SUP]8[/SUP]; Nora K. Kelly, MPH[SUP]8[/SUP]; Hillary Spencer, MD[SUP]9[/SUP][SUP],10[/SUP]; Irina Tabidze, MD[SUP]10[/SUP]; Massimo Pacilli[SUP]10[/SUP]; Carol-Ann Swain, PhD[SUP]11[/SUP]; Kathleen Bogucki, MPH[SUP]11[/SUP]; Charlotte DelBarba, MPH[SUP]11[/SUP]; Deepa T. Rajulu, MS[SUP]11[/SUP]; Andre Dailey, MSPH[SUP]1[/SUP]; Jessica Ricaldi, MD, PhD[SUP]1[/SUP]; Leandro A. Mena, MD[SUP]1[/SUP]; Demetre Daskalakis, MD[SUP]1[/SUP]; Laura H. Bachmann, MD[SUP]1[/SUP]; John T. Brooks, MD[SUP]1[/SUP]; Alexandra M. Oster, MD[SUP]1[/SUP]; Monkeypox, HIV, and STI Team
High prevalences of HIV and other sexually transmitted infections (STIs) have been reported in the current global mon- keypox outbreak, which has affected primarily gay, bisexual, and other men who have sex with men (MSM) (1–5). In previ- ous monkeypox outbreaks in Nigeria, concurrent HIV infec- tion was associated with poor monkeypox clinical outcomes (6,7). Monkeypox, HIV, and STI surveillance data from eight U.S. jurisdictions* were matched and analyzed to examine HIV and STI diagnoses among persons with monkeypox and assess differences in monkeypox clinical features according to HIV infection status. Among 1,969 persons with monkeypox during May 17–July 22, 2022, HIV prevalence was 38%, and 41% had received a diagnosis of one or more other reportable STIs in the preceding year. Among persons with monkeypox and diagnosed HIV infection, 94% had received HIV care in the preceding year, and 82% had an HIV viral load of <200 copies/mL, indicating HIV viral suppression. Compared with persons without HIV infection, a higher proportion of persons with HIV infection were hospitalized (8% versus 3%). Persons with HIV infection or STIs are disproportionately represented among persons with monkeypox. It is important that public health officials leverage systems for delivering HIV and STI care and prevention to reduce monkeypox incidence in this population. Consideration should be given to prioritizing persons with HIV infection and STIs for vaccination against monkeypox. HIV and STI screening and other recommended preventive care should be routinely offered to persons evaluated for monkeypox, with linkage to HIV care or HIV preexposure prophylaxis (PrEP) as appropriate.
Eight health departments matched probable and confirmed cases of monkeypox† diagnosed through July 22, 2022, and occurring among persons aged ≥18 years, to local HIV and STI surveillance data using individually established meth- ods that included various personal identifiers
https://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7136a1-H.pdf
http://dx.doi.org/10.15585/mmwr.mm7136a1
Kathryn G. Curran, PhD[SUP]1[/SUP]; Kristen Eberly, MPH[SUP]1[/SUP]; Olivia O. Russell, MPH[SUP]2[/SUP]; Robert E. Snyder, PhD[SUP]3[/SUP]; Elisabeth K. Phillips, MPH[SUP]3[/SUP]; Eric C. Tang, MD[SUP]3[/SUP]; Philip J. Peters, MD[SUP]1[/SUP][SUP],3[/SUP]; Melissa A. Sanchez, PhD[SUP]4[/SUP]; Ling Hsu, MPH[SUP]4[/SUP]; Stephanie E. Cohen, MD[SUP]4[/SUP]; Ekow K. Sey, PhD[SUP]5[/SUP]; Sherry Yin, MPH[SUP]5[/SUP]; Chelsea Foo, MPH[SUP]5[/SUP]; William Still, MS[SUP]6[/SUP]; Anil Mangla, PhD[SUP]6[/SUP]; Brittani Saafir-Callaway, PhD[SUP]6[/SUP]; Lauren Barrineau-Vejjajiva, MPH[SUP]7[/SUP]; Cristina Meza, MPH[SUP]7[/SUP]; Elizabeth Burkhardt, MSPH[SUP]7[/SUP]; Marguerite E. Smith, MS, MPH[SUP]8[/SUP]; Patricia A. Murphy, MPH[SUP]8[/SUP]; Nora K. Kelly, MPH[SUP]8[/SUP]; Hillary Spencer, MD[SUP]9[/SUP][SUP],10[/SUP]; Irina Tabidze, MD[SUP]10[/SUP]; Massimo Pacilli[SUP]10[/SUP]; Carol-Ann Swain, PhD[SUP]11[/SUP]; Kathleen Bogucki, MPH[SUP]11[/SUP]; Charlotte DelBarba, MPH[SUP]11[/SUP]; Deepa T. Rajulu, MS[SUP]11[/SUP]; Andre Dailey, MSPH[SUP]1[/SUP]; Jessica Ricaldi, MD, PhD[SUP]1[/SUP]; Leandro A. Mena, MD[SUP]1[/SUP]; Demetre Daskalakis, MD[SUP]1[/SUP]; Laura H. Bachmann, MD[SUP]1[/SUP]; John T. Brooks, MD[SUP]1[/SUP]; Alexandra M. Oster, MD[SUP]1[/SUP]; Monkeypox, HIV, and STI Team
High prevalences of HIV and other sexually transmitted infections (STIs) have been reported in the current global mon- keypox outbreak, which has affected primarily gay, bisexual, and other men who have sex with men (MSM) (1–5). In previ- ous monkeypox outbreaks in Nigeria, concurrent HIV infec- tion was associated with poor monkeypox clinical outcomes (6,7). Monkeypox, HIV, and STI surveillance data from eight U.S. jurisdictions* were matched and analyzed to examine HIV and STI diagnoses among persons with monkeypox and assess differences in monkeypox clinical features according to HIV infection status. Among 1,969 persons with monkeypox during May 17–July 22, 2022, HIV prevalence was 38%, and 41% had received a diagnosis of one or more other reportable STIs in the preceding year. Among persons with monkeypox and diagnosed HIV infection, 94% had received HIV care in the preceding year, and 82% had an HIV viral load of <200 copies/mL, indicating HIV viral suppression. Compared with persons without HIV infection, a higher proportion of persons with HIV infection were hospitalized (8% versus 3%). Persons with HIV infection or STIs are disproportionately represented among persons with monkeypox. It is important that public health officials leverage systems for delivering HIV and STI care and prevention to reduce monkeypox incidence in this population. Consideration should be given to prioritizing persons with HIV infection and STIs for vaccination against monkeypox. HIV and STI screening and other recommended preventive care should be routinely offered to persons evaluated for monkeypox, with linkage to HIV care or HIV preexposure prophylaxis (PrEP) as appropriate.
Eight health departments matched probable and confirmed cases of monkeypox† diagnosed through July 22, 2022, and occurring among persons aged ≥18 years, to local HIV and STI surveillance data using individually established meth- ods that included various personal identifiers
https://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7136a1-H.pdf